| Sources | Names Used |
|---|---|
| CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
| PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MNDA | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | ADGRF4 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | PLEKHH1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | PYCARD | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | RTKN | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | RAB7B | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | TREH | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | TMEM263 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | SPI1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | LILRA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
